• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD SAF-T-INTIMA¿ IV CATHETER SAFETY SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD SAF-T-INTIMA¿ IV CATHETER SAFETY SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383312
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/08/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that 5 of the bd saf-t-intima¿ iv catheter safety system experienced foreign matter, contaminated.The following information was provided by the initial reporter, translated from chinese to english: in thoracic surgery, when the package was opened, it was found that there was a foreign object on the needle tip, which was very obvious like glue.
 
Additional Manufacturer Narrative
The following fields have been updated due to additional information: d.9.Device available for eval?: yes.D.9.Returned to manufacturer on: 14-jul-2023.H.6.Investigation summary: bd received 3 samples and 2 photos submitted for evaluation.The reported issue of foreign matter was confirmed upon visual inspection of the samples.Visual examination showed that excess medical grade silicone from our lubrication process was found within the catheter of the samples stuck to the needle.Since the production of this product has been moved, no further actions will be taken at this manufacturing facility.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.H3 other text : see h10.
 
Event or Problem Description
It was reported that 5 of the bd saf-t-intima¿ iv catheter safety system experienced foreign matter, contaminated.The following information was provided by the initial reporter, translated from chinese to english: in thoracic surgery, when the package was opened, it was found that there was a foreign object on the needle tip, which was very obvious like glue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD SAF-T-INTIMA¿ IV CATHETER SAFETY SYSTEM
Common Device Name
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17181376
Report Number1710034-2023-00707
Device Sequence Number6809534
Product Code FOZ
UDI-Device Identifier00382903833122
UDI-Public00382903833122
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K013800
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date08/31/2025
Device Catalogue Number383312
Device Lot Number1243066
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/26/2023
Supplement Date Received by Manufacturer08/07/2023
Initial Report FDA Received Date06/22/2023
Supplement Report FDA Received Date08/22/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/29/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-